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Abstract
To explore the discriminatory power of matrix-assisted laser desorption ioniza-
tion-time of flight mass spectrometry (MALDI-TOF MS) for detecting subtle
differences in isogenic isolates, we tested isogenic strains of Staphylococcus aureus
differing in their expression of resistance to methicillin or teicoplanin. More
important changes in MALDI-TOFMS spectra were found with strains differing in
methicillin than in teicoplanin resistance. In comparison, very minor or no
changes were recorded in pulsed-field gel electrophoresis profiles or peptidoglycan
muropeptide digest patterns of these strains, respectively. MALDI-TOF MS might
be useful to detect subtle strain-specific differences in ionizable components
released from bacterial surfaces and not from their peptidoglycan network.
Introduction
The bacterial cell surface is a rich source of potential
biomarkers that include cell receptors, adhesins, and anti-
genic determinants. Recent developments in a number of
mass spectrometry techniques in particular matrix-assisted
laser desorption ionization time of flight mass spectrometry
(MALDI-TOF MS) have provided opportunities to rapidly
evaluate the surface of intact cells. MALDI-TOF MS allows
direct analysis of surface components from bacterial colony
suspensions. Sample preparation is simple and the analysis
automated.
MALDI-TOF MS of intact microorganisms has been
shown to produce characteristic mass spectral fingerprints
of moieties desorbed from the cell surface (Claydon et al.,
1996; Holland et al., 1996; Krishnamurthy et al., 1996;
Welham et al., 1998; Bright et al., 2002; Keys et al., 2004),
allowing this information to be used for rapid identification
of Gram-negative and Gram-positive species and even
differentiate between strains of the same species (Fenselau,
1994; Claydon et al., 1996; Bernardo et al., 2002; Du et al.,
2002; Walker et al., 2002). Since many surface properties
influence microbial physiology (e.g. electron transport, sig-
nal transduction), and virulence (e.g. toxin assemble, hae-
magglutins, ligands, binding receptors), it can also provide
information on global modifications of such cell surface
components (Shah et al., 2002; Keys et al., 2004). Moreover,
MALDI-TOFMS has also been used to identify the impact of
stress exposure on surface composition, e.g. in bifidobacteria
exposed to bile salts (Marvin-Guy et al., 2004).
In order to explore the discriminatory power of MALDI-
TOF MS for detecting subtle differences in isogenic isolates,
we used a panel of previously described isogenic strains of
Staphylococcus aureus differing in their expression of anti-
biotic resistance (Vaudaux et al., 2001, 2003; Renzoni et al.,
2004). Indeed emergence of multiresistant isolates repre-
sents a major threat for hospitalized patients. The prototype
of such multiresistant hospital isolates is the methicillin-
resistant S. aureus (MRSA), frequently associated with
multiple additional resistance determinants (Waldvogel,
1999). The glycopeptide antibiotics vancomycin and teico-
planin are the most commonly used drugs to treat such
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MRSA infections. Glycopeptides act by binding to the D-
Ala–D-Ala termini of the nascent lipid II-linked murein
precursor thereby inhibiting the polymerization of the
bacterial wall glycan chains, and hence the cross-linking of
the peptide moiety of the peptidoglycan. Teicoplanin-resis-
tant isolates selected by glycopeptide therapy frequently
exhibit a greater increase in minimal inhibitory concentra-
tions (MICs) of teicoplanin than of vancomycin (Kaatz
et al., 1990). A similar observation was made after in vitro
selection of organisms resistant to teicoplanin compared
with those resistant to vancomycin (Kaatz et al., 1990; Shlaes
et al., 1993; Mainardi et al., 1995). Detailed characterization
of clinical isolates and in vitro-selected glycopeptide-resis-
tant subpopulations indicated frequent changes in cell wall
thickening and metabolism (Daum et al., 1992; Shlaes et al.,
1993; Mainardi et al., 1995; Sieradzki & Tomasz, 1996, 1997,
1998, 1999; Hiramatsu et al., 1997; Moreira et al., 1997;
Hanaki et al., 1998; Hiramatsu, 1998; Sieradzki et al., 1999;
Cui et al., 2000; Kuroda et al., 2000; Boyle-Vavra et al., 2001;
Komatsuzawa et al., 2002).
The aim of this report was to evaluate the sensitivity and
specificity of MALDI-TOFMS for detecting potential altera-
tions on the surface of the previously described isogenic
S. aureus isolates differing in their expression of methicillin
or teicoplanin resistance (Vaudaux et al., 2001; Vaudaux
et al., 2003; Renzoni et al., 2004). For comparison, the
pulsed-field gel electrophoresis (PFGE) patterns and the
peptidoglycan muropeptide patterns obtained from enzy-
matic digests of these isolates were also examined (Glauner,
1988; de Jonge et al., 1993; Murchan et al., 2003).
Materials and methods
Bacterial strains
The properties of MRSA teicoplanin-susceptible (Teis) par-
ental strain MRGR3, its stable teicoplanin-resistant (Teir)
derivative strain 14-4 and its teicoplanin-sensitive revertant,
strain 14-4rev were previously described (Renzoni et al.,
2004). In addition, a spontaneous methicillin-susceptible
revertant of MRGR3, strain Rev1 was also studied (Vaudaux
et al., 2003; Renzoni et al., 2004). The strains were stored
at  70 1C in skimmed milk. They were cultured on
Columbia blood agar (Oxoid, Basingstoke, UK) supplemen-
ted with 5% [volume in volume (v/v)] horse blood (TCS
Microbiology, Bucks, UK) at 37 1C. Their identity was
confirmed by a real-time PCR method (Lausanne University
Hospital, Lausanne, Switzerland) for the femA gene (to
confirm that they were Staphylococcus aureus) and mecA
gene (to confirm their resistance to methicillin). Primary
sub-cultures were used for PFGE analysis, peptidoglycan
muropeptide analysis and MALDI-TOF MS. MICs of
teicoplanin for strain MRGR3, 14-4, 14-4rev are 1-2, 16
and 1 mgmL1, respectively, in cation adjusted Mueller-
Hinton broth (Renzoni et al., 2004). Except for the loss of
the methicillin resistance element, strain Rev1 exhibits an
antibiotic resistance pattern identical to its MRSA parent
(Vaudaux et al., 2003).
MALDI-TOF MS of intact bacterial cells
Bacteria were cultured on Columbia blood agar supplemen-
ted with 5% (v/v) horse blood at 37 1C. Single colonies
grown for 24 h were removed from plates using a sterile loop
and applied directly onto a 96-position MALDI sample
target [Waters Corporation (Micromass Ltd), Manchester,
UK]. The samples were allowed to air dry for 5min before
being overlaid with 1 mL of 5-chloro-2-mercaptobenzothia-
zole (3mgmL1) saturated solution in water, methanol, and
acetonitrile, (1 : 1 : 1), 0.1% formic acid and 0.01M 18-
crown-6-ether (Keys et al., 2004). The prepared target was
air dried for 1 h prior to MALDI-TOF analysis in linear
positive ion mode using the MALDI Linear Time of Flight
Mass Spectrometer (Micromass) using the conditions de-
scribed by Keys et al. (2004). Mass spectra were analysed in
batches of 12 replicates from each strain and compared for
reproducibility using the root mean square (RMS) value,
obtained by comparing each replicate in turn with the
average of the other 11 replicates. An RMS rejection value
of 3.0 was used to identify outliers significant at the 0.1%
level (Keys et al., 2004). Average spectra were produced for
inclusion in a personalised peak database using the Mi-
crobeLynxTM software (Micromass). Data processing and
comparison of representative spectra of each test strain were
compared to those already included in the MicrobeLynxTM
release database software as previously described in detail
(Keys et al., 2004).
PFGE analysis
DNA was extracted from overnight cultures in brain heart
infusion broth, digested with SmaI and electrophoresed as
previously described (Murchan et al., 2003). Gels were
analysed by BIONUMERICSTM software (Applied Maths BVBA,
Sint-Martens-Lantem, Belgium).
Peptidoglycan muropeptide analysis
Insoluble peptidoglycan was purified from cultures grown to
mid-log phase in brain heart infusion broth using a pre-
viously described standard procedure (de Jonge et al., 1992;
Majcherczyk et al., 2003). After removal of teichoic acids by
hydrofluoric acid insoluble peptidoglycan was digested with
muramidase, yielding soluble muropeptides (de Jonge et al.,
1992). These were reduced with sodium borohydride, prior
to separation by HPLC as previously described (de Jonge
et al., 1992).
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Results and discussion
MALDI-TOF MS of whole bacterial cells
Initially, the test strains were analysed by MALDI-TOF MS
and the resulting spectra of their ionisable cell surface
components compared to spectra in the release database
provided with MICROBELYNXTM software. MALDI-TOF MS of
the 12 replicates for our test strains revealed highly repro-
ducible (RMSo 3) ion spectra. The average spectra of our
test strains closely matched spectra of reference Staphylococ-
cus aureus strains in the MicrobeLynxTM software database,
namely MSSA Rev1 with MSSA NCTC8532, MRSA Teis
MRGR3 with MRSA NCTC13131, MRSA Teir 14-4 with
MRSA NCTC13138, and MRSA Teis 14-4rev with MRSA
NCTC13131. Previous studies have reported that the spec-
trum was dependent on growth conditions of the strains
before analysis and on the media used (Walker et al., 2002).
To minimise these effects all strains were cultured simulta-
neously on the same batch of medium. Reproducible results
were obtained by using fresh cultures from different days.
Subsequently, spectra of the test strains were compared
between themselves to see if differences could be observed
between the isogenic test strains. Average spectra of strains
Rev1, MRGR3, 14-4, and 14-4rev, are shown in Fig. 1. Visual
inspection alone of the different spectra mainly shows the
absence of a group of peaks around 2450Da in Rev1 that is
consistently present in the other strains tested. This suggests
that the presence of the mec-element in the MRSA strains
contributes to this group of peaks and is an agreement with
previous studies that have shown major differences in
spectra of MSRSA and MSSA and it served as a control in
our study (Bernardo et al., 2002; Du et al., 2002; Walker
et al., 2002). Among the three MRSA strains differing in
their teicoplanin susceptibilities, we noticed an increased
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Fig. 1. Average spectra of the different strains
tested. (a) MSSA strain Rev1; (b) methicillin-
resistant Staphylococcus aureus (MRSA) teico-
planin-susceptible strain MRGR3; (c) its iso-
genic teicoplanin-resistant strain 14-4; (d) its
isogenic teicoplanin-susceptible revertant 14-
4rev.
Table 1. Test strain spectra were compared with spectra in the MICROBE-
LYNX
TM personalized () and software release () databases
Test
strain
RMS values of database matched strain
Rev1 MRGR3 14-4
14-
4rev
MSSA
8532
MRSA
13131
MRSA
13138
Rev1 0.58 nr nr nr 2.76 nr nr
MRGR3 nr 0.72 1.72 1 nr 3.13 3.31
14-4 nr 2.31 0.7 3.03 nr 6.88 4.2
14-4 rev nr 0.98 1.96 0.72 nr 2.34 2.85
Root mean square (RMS) values indicate the similarity between test strain
spectra and database spectra. The lower the RMS, the greater the similarity.
RMSo 1, very high similarity; RMS4 1 and o 2, high similarity; RMS 4 2
and o 3, similar; RMS4 3 and o 4, low similarity; RMS4 4 ando 7,
very low similarity; nr, not related.
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intensity in some minor peaks at o 2400 Da in Teir 14-4
compared to Teis 14-rev and MRGR3.
A more accurate comparison of the test strains’ spectra
was achieved by using MICROBELYNXTM software. These results
confirmed the visual impression that the MSSA Rev1
spectrum was significantly different (RMS4 7) from that
of its isogenic MRSA counterparts (see Table 1). Among the
latter strains, Teis MRGR3 and 14-4rev were more closely
related to each other (RMSo 1.5) than to Teir 14-4
(RMS4 1.5). Figure 2 shows these results more clearly in
the form of a cluster analysis. These results indicate that
MALDI TOF MS can differentiate between isogenic strains
of MRSAwith different susceptibilities to teicoplanin. More-
over, the fact that MALDI-TOF MS analyses ionisable
components from the cell surface strongly suggests the
contribution of some unknown surface components to the
strain-specific spectral differences.
PFGE analysis
Figure 3 shows the PFGE patterns of the strains tested.
MRGR3, 14-4rev and 14-4 yielded identical PFGE patterns
except for a single-band difference in 14-4. The MSSA Rev1
had a three-band difference compared with the other MRSA
strains tested. MALDI-TOF MS clustered (Fig. 2) the same
strains together as the PFGE analysis (Fig. 3): MRSA and 14-
4rev were more closely related to 14-4 than to Rev1.
Muropeptide digest pattern analysis
To evaluate the potential contribution of cell wall peptido-
glycan to MALDI-TOF MS-TOF MS strain-specific differ-
ences, we analysed solubilized muropeptides purified from
each strain’s peptidoglycan. As shown in Fig. 4, all tested
Fig. 2. Cluster analysis of mass spectra of the strains tested. Mass
spectra were analysed with MICROBELYNXTM software. Relative Diff. repre-
sents relative difference, a relative scale normalized between 0 and 1. A
difference of 0 indicates the clusters are exactly the same. A difference of
1 indicates that the clusters are the least similar clusters in the current
data set.
Fig. 3. Pulsed-field gel electrophoresis patterns of the strains tested.
DNA was digested with SmaI and electrophoresed. Gels were analysed
by the BIONUMERICSTM software. Relative similarity is a relative normalized
scale between 100 and 0. A similarity of 100 indicates the clusters are
exactly the same. A similarity of 0 indicates that the clusters are the least
similar in the current data set.
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strains yielded identical muropeptide patterns, thus provid-
ing evidence that their peptidoglycan scaffold skeleton did
not contribute to the cell surface alterations revealed by
MALDI-TOF MS. These results support previous observa-
tions of de Jonge et al. who demonstrated that the muropep-
tide digest pattern of an MRSA strain was not significantly
influenced by inactivation or deletion of the mec gene (de
Jonge et al., 1992).
Conclusions
Our observations that MALDI-TOF MS can easily differ-
entiate between three isogenic MRSA derivatives and its
spontaneously arising MSSAwithout showing any difference
in their peptidoglycan muropeptide digest patterns bring
additional support to previous observations reported by
other laboratories that showed the power of MALDI-TOF
MS for discriminating MRSA from MSSA strains of un-
related background (Edwards-Jones et al., 2000; Bernardo
et al., 2002; Du et al., 2002; Walker et al., 2002). The present
study brings further evidence that MALDI-TOF can success-
fully differentiate between isogenic strains considered iden-
tical by PFGE analysis. Our own data obtained on isogenic
MRSA and MSSA isolates may facilitate identification of
putative surface components altered by expression of anti-
biotic resistance. Further studies need to be performed on
larger panels of isogenic antibiotic-resistant or susceptible
isolates to evaluate the potential of MALDI-TOF MS for
clinical microbiology applications.
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